Bio-Techne
TECH
292 hedge funds and large institutions have $4.46B invested in Bio-Techne in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 105 increasing their positions, 102 reducing their positions, and 17 closing their positions.
100% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 17
4% more funds holding
Funds holding: 280 → 292 (+12)
3% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 102
2% more capital invested
Capital invested by funds: $4.39B → $4.46B (+$68.8M)
4% less call options, than puts
Call options by funds: $931K | Put options by funds: $967K
5.7% less ownership
Funds ownership: 400.56% → 394.86% (-5.7%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
Millennium Management
New York
|
+$18M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$13.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$13M |
| 4 |
Renaissance Technologies
New York
|
+$11.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.12M |
Top Sellers
| 1 |
Select Equity Group
New York
|
-$36.6M |
| 2 |
SCM
SG Capital Management
Chicago,
Illinois
|
-$24.1M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$20.8M |
| 4 |
Goldman Sachs
New York
|
-$11.9M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$11.4M |
TECH Hedge Fund Activity: Q3 2017 in Review
292 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2017, worth a combined $4.46B — up 1.6% from $4.39B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new TECH positions and 17 closed out — a net gain of 17 holders — while 105 added to existing stakes and 102 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $18M. The largest seller was Select Equity Group, cutting an estimated $36.6M.
- 292 institutional investors held Bio-Techne (TECH) as of Q3 2017, up from 280 in Q2 2017.
- Funds reported $4.46B of Bio-Techne stock for Q3 2017, up 1.6% quarter-over-quarter.
- 34 funds opened new Bio-Techne positions in Q3 2017 and 17 closed out, a net change of +17 holders.
- The largest Bio-Techne buyer in Q3 2017 was Millennium Management, an estimated $18M added.
- The largest Bio-Techne seller in Q3 2017 was Select Equity Group, an estimated $36.6M sold.
Based on aggregated 13F filings for Q3 2017.